Yi F. Shi
Changhongjie, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment.
Journal: Journal for immunotherapy of cancer
Published: January 07, 2026
Pseudoginsenoside F11 enhances YBX1-mediated transcriptional repression of PRPS2 to inhibit the stemness and pulmonary metastasis of triple- negative breast cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 02, 2025
Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer.
Journal: Redox biology
Published: July 22, 2025
Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment.
Journal: Journal of medicinal chemistry
Published: July 10, 2025
Application Practice of AI Empowering Post-discharge Specialized Disease Management in Postoperative Rehabilitation of the Lung Cancer Patients Undergoing Surgery
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 10, 2025
Metabolic gatekeeper ACAD9 coordinates linoleic acid metabolism and redox homeostasis via mitochondrial complex I to drive ovarian cancer progression.
Journal: Cancer letters
Published: March 08, 2025
Adipocyte-specific Zeb1 downregulation remodels the tumor-associated adipose microenvironment to facilitate female breast cancer progression.
Journal: Nature communications
Published: August 29, 2024
Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer.
Journal: European journal of medicinal chemistry
Published: June 17, 2024
Last Updated: 09/26/2026